Reuters logo
BRIEF-Quidel receives FDA clearance and CLIA waiver
2017年6月28日 / 晚上8点56分 / 4 个月前

BRIEF-Quidel receives FDA clearance and CLIA waiver

June 28 (Reuters) - Quidel Corp:

* Quidel receives FDA clearance and CLIA waiver for its point-of-care sofia 2 instrument for use with sofia respiratory syncytial virus (RSV) assay Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below